| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEODERIV | Sep 3 | D | 253,016 | — | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEODERIV | Sep 3 | D | 357,036 | — | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEODERIV | Sep 3 | D | 387,012 | — | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Sep 3 | D | 920,941 | — | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jul 10 | GPLAN | 75,046 | $0.00 | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jul 8 | SPLAN | 20,000 | $133.63 | $2.7M |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 22 | SPLAN | 80,000 | $132.54 | $10.6M |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | Jun 22 | SPLAN | 20,000 | $100.00 | $2.0M |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 614 | $86.89 | $53K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 2,305 | $86.27 | $199K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 1,577 | $85.19 | $134K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 1,080 | $84.18 | $91K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 7,654 | $82.78 | $634K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jun 10 | SPLAN | 6,770 | $82.21 | $557K |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDirDERIV | May 27 | A | 8,026 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | May 13 | SPLAN | 1,341 | $82.58 | $111K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | May 13 | SPLAN | 18,659 | $82.05 | $1.5M |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | May 8 | SPLAN | 19,269 | $75.35 | $1.5M |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | May 8 | SPLAN | 24,814 | $74.76 | $1.9M |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | May 8 | SPLAN | 33,513 | $73.72 | $2.5M |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | May 8 | SPLAN | 2,404 | $72.57 | $174K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEODERIV | Apr 16 | M | 3,000 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Apr 16 | M | 3,000 | $22.86 | $69K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Apr 8 | SPLAN | 200 | $85.00 | $17K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Apr 8 | SPLAN | 2,000 | $83.26 | $167K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Apr 8 | SPLAN | 17,800 | $82.48 | $1.5M |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Mar 11 | SPLAN | 3,418 | $75.86 | $259K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Mar 11 | SPLAN | 8,219 | $74.83 | $615K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Mar 11 | SPLAN | 8,363 | $74.29 | $621K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Feb 11 | SPLAN | 955 | $64.99 | $62K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Feb 11 | SPLAN | 7,551 | $63.73 | $481K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Feb 11 | SPLAN | 11,494 | $62.96 | $724K |
| Spyre Therapeutics, Inc. | SYRE | Michael Thomas HendersonDir | Jan 21 | J | 63,227 | $0.00 | — |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 470 | $83.79 | $39K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 5,386 | $83.16 | $448K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 1,854 | $82.41 | $153K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 2,374 | $81.00 | $192K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 8,476 | $79.82 | $677K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Jan 14 | SPLAN | 1,440 | $78.64 | $113K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEODERIV | Jan 2 | A | 253,016 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Dec 10 | SPLAN | 560 | $76.58 | $43K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Dec 10 | SPLAN | 10,005 | $75.79 | $758K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Dec 10 | SPLAN | 9,435 | $74.88 | $706K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Dec 4 | SPLAN | 40,000 | $75.01 | $3.0M |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Nov 13 | SPLAN | 100 | $64.52 | $6K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Nov 13 | SPLAN | 1,786 | $63.89 | $114K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Nov 13 | SPLAN | 14,774 | $63.14 | $933K |
| Apogee Therapeutics, Inc. | APGE | Michael Thomas HendersonCEO | Nov 13 | SPLAN | 3,340 | $61.93 | $207K |